IVF/ICSI outcome and serum LH concentration on day 1 of ovarian stimulation with recombinant FSH under pituitary suppression
article
OA: bronze
CC0
⤵ 1 in-corpus citation
AI-generated summary
Serum LH concentration on stimulation day 1 does not predict ovarian response, conception, or pregnancy outcome in women undergoing IVF/ICSI after pituitary suppression with GnRH agonist.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
BACKGROUND: Down-regulation with GnRH agonist has been suggested to result in a profound suppression of LH bioactivity, reduced estradiol synthesis, and thus impaired IVF and pregnancy outcome. The aims of this study were: (i) to assess the usefulness of serum LH measurement on stimulation day 1 as a predictor of ovarian response, conception and pregnancy outcome in patients treated with long-term down-regulation with GnRH agonist and recombinant FSH, and (ii) to define the best threshold LH value, if any, to discriminate between women with different outcomes of IVF. METHODS: Records of 2625 cycles in 1652 infertile women undergoing IVF (n = 1856) and/or ICSI (n = 769) treatment were reviewed. RESULTS: The range of LH concentrations on stimulation day 1 overlapped among non-conception cycles, conception cycles, ongoing pregnancies and early pregnancy losses. Receiver operating characteristic (ROC) analysis showed that serum LH concentrations on stimulation day 1 were unable to discriminate between conception and non-conception cycles (AUC(ROC) = 0.51; 95% CI: 0.49-0.54) or ongoing pregnancies versus early pregnancy loss groups (AUC(ROC) = 0.52; 95% CI: 0.47-0.57). Stratification for various low serum levels of LH did not reveal significant differences with respect to conception or pregnancy outcome among different LH levels on stimulation day 1. CONCLUSIONS: Serum LH concentration on stimulation day 1 cannot predict ovarian response, conception and pregnancy outcome in women receiving long-term down-regulation during assisted reproduction treatment.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (4)
- Effect of endometriosis on in vitro fertilization 2002
- Expression Profiling of Endometrium from Women with Endometriosis Reveals Candidate Genes for Disease-Based Implantation Failure and Infertility 2003
- Effect of prolonged gonadotropin-releasing hormone agonist therapy on the outcome of in vitro fertilization-embryo transfer in patients with endometriosis 2002
- Assessment of the role of serum luteinizing hormone and estradiol response to follicle-stimulating hormone on in vitro fertilization treatment outcome 1997
Cited by (1)
References (37)
- Assessment of the role of serum luteinizing hormone and estradiol response to follicle-stimulating hormone on in vitro fertilization treatment outcome via openalex
- Effect of endometriosis on in vitro fertilization via openalex
- Effect of prolonged gonadotropin-releasing hormone agonist therapy on the outcome of in vitro fertilization-embryo transfer in patients with endometriosis via openalex
- Expression Profiling of Endometrium from Women with Endometriosis Reveals Candidate Genes for Disease-Based Implantation Failure and Infertility via openalex
- doi:10.1093/humrep/16.8.1636 via openalex
- doi:10.1093/oxfordjournals.humrep.a019357 via openalex
- doi:10.1093/oxfordjournals.humrep.a135930 via openalex
- doi:10.1093/humrep/15.7.1440 via openalex
- doi:10.1210/endo-28-1-33 via openalex
- doi:10.1034/j.1600-0412.1998.770813.x via openalex
- doi:10.1016/s0015-0282(02)03157-6 via openalex
- doi:10.1016/s0015-0282(01)01973-2 via openalex
- doi:10.1093/humrep/13.5.1292 via openalex
- doi:10.1016/j.fertnstert.2004.06.050 via openalex
- doi:10.1093/oxfordjournals.humrep.a019039 via openalex
- doi:10.1093/humrep/13.3.567 via openalex
- doi:10.1016/s0015-0282(16)54715-3 via openalex
- doi:10.1080/j.1600-0412.1998.770813.x via openalex
- doi:10.1016/s0015-0282(16)49159-4 via openalex
- doi:10.1016/s0015-0282(16)58201-6 via openalex
- doi:10.1080/gye.15.6.407.412 via openalex
- doi:10.1016/j.fertnstert.2004.07.969 via openalex
- doi:10.1093/humrep/17.8.2016 via openalex
- doi:10.1148/radiology.143.1.7063747 via openalex
- doi:10.1093/clinchem/39.4.561 via openalex
- doi:10.1093/humrep/15.5.1003 via openalex
- doi:10.1016/s0015-0282(16)54965-6 via openalex
- doi:10.1111/j.1479-828x.1997.tb02226.x via openalex
- doi:10.1210/jcem.74.6.1592896 via openalex
- doi:10.1093/oxfordjournals.humrep.a136154 via openalex
- doi:10.1093/oxfordjournals.humrep.a137513 via openalex
- doi:10.1016/s0015-0282(16)57734-6 via openalex
- doi:10.1210/jcem-28-3-355 via openalex
- doi:10.1093/humrep/14.2.288 via openalex
- doi:10.1093/humrep/13.7.1788 via openalex
- doi:10.1093/humrep/15.11.2333 via openalex
- doi:10.1016/s0015-0282(97)00509-8 via openalex
Cited by (1)
SciLite annotations
chemicals 1
estradiol
Source provenance
- openalex
- last seen: 2026-05-11T05:42:58.953575+00:00
- scilite
- last seen: 2026-05-18T04:26:01.642840+00:00
License: CC0
· commercial use OK